Paul McLean

Title: The Innovations of Paul McLean

Introduction

Paul McLean is an accomplished inventor based in Lexington, MA (US). He has made significant contributions to the field of biochemistry, particularly in the purification of glycosidase-cleaving enzymes. His innovative work has led to the development of a patented method that enhances the efficiency of enzyme purification processes.

Latest Patents

Paul McLean holds a patent for "Affinity purification of glycosidase-cleaving enzymes." This invention relates to an affinity resin that is functionalized with small molecule inhibitors of glycoside-cleaving enzymes, such as α-galactosidase A, glucocerebrosidase, β-galactosidase, and acid alpha-glucosidase. The method he developed allows for the purification of these enzymes produced in a cell line using the small molecule inhibitor-functionalized affinity resin. He has 1 patent to his name.

Career Highlights

Paul McLean is currently employed at Takeda Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His work at Takeda has positioned him as a key player in the pharmaceutical industry, contributing to innovative solutions in enzyme purification.

Collaborations

Throughout his career, Paul has collaborated with notable colleagues, including Brian Dwyer and Bohong Zhang. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Paul McLean's contributions to the field of biochemistry through his innovative patent and work at Takeda Pharmaceutical Company Limited highlight his dedication to advancing enzyme purification methods. His achievements reflect the importance of innovation in the pharmaceutical industry.